Pacific Biosciences Of California Inc (NASDAQ:PACB) Institutional Investors Q1 2018 Sentiment

June 14, 2018 - By Kurt Siggers

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Logo

Sentiment for Pacific Biosciences Of California Inc (NASDAQ:PACB)

Pacific Biosciences Of California Inc (NASDAQ:PACB) institutional sentiment increased to 1.93 in 2018 Q1. Its up 0.80, from 1.13 in 2017Q4. The ratio is positive, as 52 hedge funds increased or opened new equity positions, while 27 reduced and sold stock positions in Pacific Biosciences Of California Inc. The hedge funds in our partner’s database reported: 88.24 million shares, up from 76.26 million shares in 2017Q4. Also, the number of hedge funds holding Pacific Biosciences Of California Inc in their top 10 equity positions was flat from 2 to 2 for the same number . Sold All: 8 Reduced: 19 Increased: 41 New Position: 11.

Pacific Biosciences of California, Inc. designs, develops, and makes sequencing systems to resolve genetically complex problems. The company has market cap of $433.88 million. The companyÂ’s single molecule real-time sequencing technology enables single molecule real-time detection of biological processes. It currently has negative earnings. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes biochemical sequencing reactions.

The stock increased 0.30% or $0.01 during the last trading session, reaching $3.29. About 1.21M shares traded or 55.38% up from the average. Pacific Biosciences of California, Inc. (NASDAQ:PACB) has declined 32.53% since June 14, 2017 and is downtrending. It has underperformed by 45.10% the S&P500.

Analysts await Pacific Biosciences of California, Inc. (NASDAQ:PACB) to report earnings on August, 1. They expect $-0.16 EPS, up 38.46 % or $0.10 from last year’s $-0.26 per share. After $-0.20 actual EPS reported by Pacific Biosciences of California, Inc. for the previous quarter, Wall Street now forecasts -20.00 % EPS growth.

Oracle Investment Management Inc holds 4.74% of its portfolio in Pacific Biosciences of California, Inc. for 9.54 million shares. Trellus Management Company Llc owns 775,000 shares or 2.89% of their US portfolio. Moreover, Consonance Capital Management Lp has 2.36% invested in the company for 12.58 million shares. The New Jersey-based Raging Capital Management Llc has invested 0.91% in the stock. Maverick Capital Ltd, a Texas-based fund reported 12.17 million shares.

More important recent Pacific Biosciences of California, Inc. (NASDAQ:PACB) news were published by: Benzinga.com which released: “45 Biggest Movers From Yesterday” on June 08, 2018, also Globenewswire.com published article titled: “Wellcome Sanger Institute Sequences Reference Genomes of 3000 Dangerous Bacteria”, Benzinga.com published: “Innovative Biotech Companies Pushing the Envelope” on June 11, 2018. More interesting news about Pacific Biosciences of California, Inc. (NASDAQ:PACB) was released by: Globenewswire.com and their article: “Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program” with publication date: June 07, 2018.

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: